Register Now

Overview

This talk will delve into new and emerging cardiovascular risk assessment tools that can be used to better personalize a patient’s cardiovascular risk and help direct individualized therapy. It will also review upcoming therapies that aim to address this residual risk.

Learning Objectives

  • Define residual cardiovascular disease risk and its role in personalized medicine
  • Identify the factors associated with residual cardiovascular disease risk
  • Discuss current tools and therapies that identify and tackle residual cardiovascular risk
  • Recognize therapies currently under investigation that address residual cardiovascular risk